Liver and biliary tract cancer trials in Poland

In Poland 22 Also abroad 1314

22 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 11 November 2026. Ask the study team whether a trial fits you.

No phaseTaking people
A Study to Evaluate Patient-Reported Satisfaction, Effectiveness, and Safety of Atezolizumab in Participants Treated in Routine Clinical Practice
Where
Krakow, Lublin, Olsztyn, Poznan, Słupsk, Tomaszów Mazowiecki
Age
18 years and over
People
700 worldwide
Run by
Hoffmann-La Roche
See details and how to joinNCT07284121
Phase 2Taking people
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
Where
Cracow
Age
18 years and over
People
750 worldwide
Run by
DualityBio Inc.
See details and how to joinNCT06953089 · EU 2025-523895-22-00
Phase 1/2Taking people
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
Where
Cracow, Lodz, Rzeszów, Siedlce, Skorzewo
Age
18 years and over
People
680 worldwide
Run by
Daiichi Sankyo
See details and how to joinNCT06330064 · EU 2023-509632-26-00
Phase 1/2Taking people
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
Where
Gdansk, Warsaw, Wroclaw
Age
18 years and over
People
198 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07291076 · EU 2025-523602-33-00
Phase 3Taking people
Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer
Where
Bialystok, Cracow, Katowice, Lublin, Warsaw
Age
18 years to 99 years
People
620 worldwide
Run by
AstraZeneca
See details and how to joinNCT06467357 · EU 2023-508057-19-00
Phase 3Taking people
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
Where
Bydgoszcz, Cracow, Gdansk, Koszalin, Lublin, Olsztyn, Warsaw
Age
18 years and over
People
1,220 worldwide
Run by
AstraZeneca
See details and how to joinNCT06921785 · EU 2024-518210-81-00
Phase 3Taking people
A clinical trial of belzutifan and other treatments in people with solid tumors or von Hippel-Lindau (VHL)-related tumors (MK-6482-043)
Where
Bydgoszcz, Warsaw
Age
18 years and over
People
134 worldwide
Run by
Merck Sharp & Dohme LLC
See details and how to join2025-524160-38-00 · EU 2025-524160-38-00
Phase 1Taking people
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
Where
Bydgoszcz, Gdansk, Otwock, Poznan, Wroclaw
Age
18 years and over
People
1,394 worldwide
Run by
Exelixis
See details and how to joinNCT05176483 · EU 2023-510061-10-00
Phase 2Taking people
AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2
Where
Cracow, Warsaw
Age
18 years and over
People
226 worldwide
Run by
AstraZeneca
See details and how to joinNCT06219941 · EU 2023-508275-37-00
Phase 3Taking people
A Study of Rilvegostomig or Durvalumab Plus Chemotherapy for First-Line Treatment of Biliary Tract Cancer (ARTEMIDE-Biliary02)
Where
Cracow, Koszalin, Lodz, Olsztyn, Warsaw
Age
18 years and over
People
1,100 worldwide
Run by
AstraZeneca
See details and how to joinNCT07221253 · EU 2025-523085-24-00
Phase 1Taking people
A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
Where
Brzozów, Koszalin, Lublin, Olsztyn, Przemyśl
Age
18 years and over
People
40 worldwide
Run by
AstraZeneca
See details and how to joinNCT07391670 · EU 2025-521639-34-00
Phase 2Taking people
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Where
Cracow, Gliwice, Warsaw
Age
18 years to 130 years
People
454 worldwide
Run by
AstraZeneca
See details and how to joinNCT05489211 · EU 2023-509436-26-00
Phase 2Taking people
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
Where
Cracow, Lublin, Otwock, Warsaw
Age
18 years and over
People
120 worldwide
Run by
Taiho Oncology, Inc.
See details and how to joinNCT05727176 · EU 2023-503665-39-00
Phase 3Taking people
A Phase III, Randomized, Controlled, Global Multicenter Study to Evaluate the Efficacy and Safety of Oral Tinengotinib versus Physician’s Choice in Subjects with Fibroblast Growth Factor Receptor (FGFR) altered, Chemotherapy- and FGFR Inhibitor-Refractory/Relapsed Cholangiocarcinoma (FIRST-308)
Where
Warsaw
Age
18 years and over
People
126 worldwide
Run by
Transthera Sciences (Nanjing) Inc.
See details and how to join2023-505660-11-00 · EU 2023-505660-11-00
Phase 4Taking people
A Study to Assess the Long-term Safety Outcomes in Patients Previously Treated With RP1, RP2, or RP3
Where
Cracow, Gdansk, Warsaw
Age
18 years and over
People
50 worldwide
Run by
Replimune, Inc.
See details and how to joinNCT06887348 · EU 2025-521621-33-00
Phase 4Taking people
HOPE Against Cancer Recurrence in HCC
Where
Gdansk, Warsaw
Age
18 years and over
People
220 worldwide
Run by
Philipp Dutkowski
See details and how to joinNCT06717919
No phaseNot yet taking people in Poland
15 vs 45 Minute Pringle Maneuver in Liver Cancer Resection: Randomized Noninferiority Trial
Where
Warsaw
Age
18 years and over
People
600
Run by
Medical University of Warsaw
See details and how to joinNCT07237204
Phase 3Taking people
A clinical trial in children and adolescents with primary malignant liver cancer - Hepatoblastoma and Hepatocarcinoma
Where
Białystok, Bydgoszcz, Gdansk, Katowice, Krakow, Łódź, Lublin, Poznań, Rzeszów, Szczecin, Warsaw, Wrocław, Zabrze
Age
Up to 64 years
People
60
Run by
Medical University Of Gdansk
See details and how to join2024-514635-26-00 · EU 2024-514635-26-00
No phaseTaking people
ctDNA Monitoring in Patients With HCC and mCRC
Where
Warsaw
Age
18 years to 75 years
People
300
Run by
Medical University of Warsaw
See details and how to joinNCT07001085
Phase 2Not yet taking people in Poland
A Phase II Study of AK104 Combination With Lenvatinib Versus Lenvatinib for Second-line HCC
Where
Koszalin, Warsaw
Age
18 years and over
People
120 worldwide
Run by
Akeso
See details and how to joinNCT06984718 · EU 2025-524591-30-00
Phase 3Taking people
Namodenoson in the Treatment of Advanced Hepatocellular Carcinoma in Patients With Child-Pugh Class B7 Cirrhosis
Where
Koszalin, Krakow, Mysłowice, Przemyśl, Warsaw, Wroclaw
Age
18 years and over
People
471 worldwide
Run by
Can-Fite BioPharma
See details and how to joinNCT05201404
No phaseTaking people
TANGO-LIVER Three Arm Nuclear Growth Observation in Liver Surgery
Where
Warsaw
Age
18 years to 80 years
People
154
Run by
Medical University of Warsaw
See details and how to joinNCT06050200